Member Info for xviolet

All sounds very promising. there must be some research (we need to do) on their tech.

and the RNS says Medi are getting ready to benefit from IB's commercial acumen.

indeed. lets hope so.

What was it...warrants at 0.2?

it was very low. lost a few rampers? they must have sold their warrants.

I have totally failed to understand this stock - need to watch the interview - for what its worth I buy some from time to time.

perhaps not the best decision I ever made - they can't all be winners...but won't say any more until I get time to watch interviews etc and find out where they are at. unless this auditor thing is a wipeout but can't really see why people gave them so much £ if they are that crxp. so....we shall see.

"Alora Pharmaceuticals hold 21,818,192 warrants. I think they will exercise their warrants and become shareholders and they could well be one of the companies that ImmuPharma are in negotiations with."

so the same money they make from selling the warrants - they then give back to IMM to fund...what? probably something like early stages clinical work to learn more about the action and potential of 140. So...you have no big pharma deal. no massive cash injection (just your cash recycled). and then...a few months later...the next fundraise - there wil be a very good reason for it...there always is. albeit at a share price higher than 1.5p.

Where is N?

probably keeping head down while the lemmings rush to lose their shirts

many find the whole sad process disheartening and distasteful

Island Girl

I am sorry to hear that. I am no spring chicken but I am not ready to lose my job - even though I know these things happen and its not our fault. My partner works in the city and she has been made redundant 3 times so far. Its never our fault. But it can be so so difficult to put up with....I am sorry you have to put up with all that. takecare.

So many posts and new posters.

right or wrong I just figured a large number of the posters were 'fake people' working (either directly or indirectly) for whoever needs to shift a large amount of stock - its like a part of a professional sales team? a marketing operation.

of course I might be wrong. I just read it that way. and sold some shares and went on holiday.

but kept a few back. lets see what happens next.

Thanks GG

I'll have to go back over the first interview. Check the second. See if there are any clues.

For me - once I get even a hint of what kind of move Tim wants to make - then we'll have a better idea of how much money he'll be looking for and what kind of timelines we are looking at.

Good weekend all.

OK. One serious question. Promise 2 behave

On the most recent interviews exactly what kind of trials or clinical work did Tim say the company was getting ready to pursue.

Has he been specific?

Risk mgmt?

nah. why bother.

Appears to be doing 2 things

waiting electricity

giving people un-readable and un-reliable answers.

i think if you want to know about 'deals' then read the actual press releases for each and every deal. and pour over whatever fine detail is in the public domain. everyone is running, I think, when they should be walking. and when you run...you miss so much. so many things you don't see. and you need to see if you are going to invest.

You can buy at the placing price now.

was wondering if it will go lower.

haven't looked at volume since placing...that might be an interesting figure.

Basically I am still holding stock. and I remain positive

I just don't believe in instant/marvelous deal - I tend to think these things are often nuanced.

but in the flurry of excitement and ramping...the details will be overlooked.

Rebarm

yeah. why not. a nice simple licensing deal. i am up for that.

i guess a good thing would be go back to 2019 and look at the RNS's that followed the last deal. and see how much £ was actually handed over to IMM.

Tyre

I don't think I've changed too much. I've never said 'deal'/instant riches.

I imagine a slow process as we move to finance the next trials and that process is difficult but also exciting for small investors.

For example...famously crxp licensing deals.

Theracryf did a deal with a pharma company who were so crxp they couldn't afford to make the second payment on the license deal. Still waiting for it - like a year later. At the time Theracryf's share price probably rocketed but the £ never arrived.

I watched the interview. One question.

What kind of licensing deal? Can we think of best case/worst case types of deals. For example (thinking worst, forgive me) don't some 'deals' come with a load of warrants attached - or perhaps a little complex in other ways.

Tim said he would be talking to potential deal partners over the next few weeks. So no RNS in the next few days then?

And I thought Sebastian was less than clear when he discussed Type M cohorts - but I need to watch it carefully again - maybe it was my listening at fault. Not his speaking.

But I would appreciate some thoughts from others who have been looking at this sector longer than me, on the nature of licensing deals - and perhaps some pointers to other deals I can look at and examine. In the past I've looked at HEMO but their deals were smoke and mirrors affairs. I will be looking at other pharma's licensing deals to see how the financing was done and what effect it had on share structure etc. But any pointers welcome. To both best and worst case deals. Thank you....good luck all.

Monte

ogm is very likely Roast PR....

aat****z

thanks. yes i will watch the interview.

for me...the one question (i'm enjoying the pondering) is why not release the 'deal' and 'patent' news at the same time. why not get it all sewn up at once. anyway lots to think about. hope everyone does well tomorrow.

Noise/board/intelligent people

yes it was so quiet a while ago

where do they all come from?

anyway I need to listen to this interview. no fundraise/no placing? he was quite specific? there was no room for doubt on that point? so no CLNs etc or any other kind of weird deal that involves issuing more shares. instead he said a 'licensing deal'. and said one was ready to go??? but he's not ready to release it as an RNS. because....because... I can't think of an answer and/or I can't be bothered to torment myself trying to find one.

Pharma will pounce.

well it would depend on the value right?

so how much is this worth - who is P140 for - the RNS said what was it 'Type M immune disorder'.

I've been looking that up on-line. DYOR!

Anyway I'm still waiting for the 'third RNS'. Either a partnership. Or a raise. Or both at the same time.